Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Seasonal Allergic Rhinitis

In brief

This study will assess the efficacy and safety of different doses of ACT-129968 in adult patients with seasonal allergic rhinitis, due to mountain cedar pollen.

Key facts

Study ID
NCT01241214
Run by
Idorsia Pharmaceuticals Ltd.
People needed
579
Starts
2010-11-01
Expected to finish
2011-02-01
Last updated by the study team
2019-05-15

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.